The content of adipokines in women with hypothyroidism and type 2 diabetes mellitus
https://doi.org/10.21518/2079-701X-2020-21-170-177
Abstract
Introduction. Type 2 diabetes mellitus (DM) and hypothyroidism are the most common endocrine pathologies. These diseases are associated with atherogenic dyslipidemia, insulin resistance, and overweight.
Aim. Тo assess the relationship between adipokines and hormone-metabolic parameters in women with hypothyroidism, type 2 diabetes mellitus and their combination.
Materials and methods. We examined 119 women aged 45 to 74 years: 42 women with primary hypothyroidism, 38 women with type 2 diabetes and 39 women with a combination of type 2 diabetes and hypothyroidism. All patients underwent an anthropometric examination, studied the indicators of lipid and carbohydrate metabolism, the content of adiponectin, leptin and resistin.
Results. In women with type 2 diabetes and its combination with hypothyroidism, hyperglycemia, hyperinsulinemia, and insulin resistance were revealed. In all groups, an increase in total cholesterol, triglycerides, atherogenic coefficient was found. The examined women with a combination of hypothyroidism and type 2 diabetes mellitus had a decreased level of adiponectin and an increased level of leptin. In patients with hypothyroidism and patients with type 2 diabetes, a decrease in adiponectin levels and an increase in leptin and resistin were revealed.
Discussion. The most pronounced hyperinsulinemia and insulin resistance were found in the group of patients with a combination of hypothyroidism and type 2 diabetes. At the same time, the combination of type 2 diabetes and hypothyroidism in the examined women, according to our data, did not aggravate lipid metabolism disorders. Against the background of visceral obesity in women with a combination of diseases, hypoadiponectinemia and hyperleptinemia were most pronounced. In this group, the level of resistin was positively correlated with the level of insulin and the index of insulin resistance.
Conclusion. In women with hypothyroidism, type 2 diabetes and their combination, atherogenic dyslipidemia, hyperleptinemia, and hypoadiponectinemia were established. Hypoadiponectinemia and hyperleptinemia are involved in the development of atherogenic dyslipidemia in women with primary hypothyroidism.
About the Authors
A. F. Verbovoy
Samara State Medical University
Russian Federation
Russian Federation
Dr. of Sci. (Med.), Professor, Head of the Department of Endocrinology,
89, Chapaevskaya St., Samara, 443099
T. V. Lomonova
Samara State Medical University
Russian Federation
Russian Federation
Postgraduate Student of the Department of Endocrinology,
89, Chapaevskaya St., Samara, 443099
References
1. Ametov A.S. Selected lectures on endocrinology. Moscow: Medical Information Agency; 2016. 720 p. (In Russ.) Available at: https://docplayer.ru/34091732-Izbrannye-lekcii-po-endokrinologii.html.
2. Garduno-Garcia Jde J., Alvirde-Garcia U., Lopez-Carrasco G., Padilla Mendoza M.E., Mehta R., Arellano-Campos O. et al. TSH and free thyroxine concentrations are associated with differing metabolic markers in euthyroid subjects. Eur J Endocrinol. 2010;163(2):273–278. doi: 10.1530/EJE-10-0312.
3. Dedov I.I., Mel’nichenko G.A., Butrova S.A. Adipose tissue as an endocrine organ. Ozhirenie i metabolism = Obesity and Metabolism. 2006;3(1):6–13. (In Russ.) doi: 10.14341/2071-8713-4937.
4. Dedov I.I., Shestakova M.V., Majorov A.Yu. (eds.) Standarts of Specialized Diabet Care. 9th ed. Sakharni Diabet = Diabetes Mellitus. 2019;22(1S1):1–144. (In Russ.) doi: 10.14341/DM221S1.
5. Petunina N.A., Truhina L.V., Martirosyan N.S. Hypothyroidism in the practice of a general practitioner: approaches to diagnosis and treatment. Terapiya = Therapy. 2017;(3):84–88. (In Russ.) Available at: https://therapyjournal.ru/ru/archive/article/34882.
6. Vyakaranam S., Vanaparthy S., Nori S., Palarapu S., Bhongir A.V. Study of insulinresistance in subclinical hypothyroidism. Int J Health Sci Res. 2014;4(9):147–153. Available at: https://pubmed.ncbi.nlm.nih.gov/25580384.
7. Bardymova T.P., Berezina M.V., Mihaleva O.G. The prevalence of obesity in patients with diabetes mellitus in Irkutsk. Sibirskiy medicinskiy zurnal (Irkutsk) = Siberian Medical Journal (Irkutsk). 2013;121(6):130–132. (In Russ.) Available at: https://elibrary.ru/item.asp?id=20607524.
8. Petunina N.A., Truhina L.V. Hypothyroidism. RMZh = RMJ. 2007;(2):89. (In Russ.) Available at: http://www.rmj.ru/articles/endokrinologiya/Gipotireoz/?print_page=Y#ixzz6h1d9GffC.
9. Kosygina A.V. Adipocytokines in scientific and clinical practice. Ozhirenie i metabolism = Obesity and Metabolism. 2011;8(1):32–39. (In Russ.) doi: 10.14341/2071-8713-5189.
10. Kadzharyan V.G., Melnik A.I., Bidzilya P.P., Solovyuk S.A. Assessment of the state of lipid exchange in thyroid dysfunction. Zaporozhskij medicinskij zhurnal = Zaporozhye Medical Journal. 2014;(1):20–22. (In Russ.) Available at: http://dspace.zsmu.edu.ua/bitstream/123456789/313/1/020-022.pdf.
11. Batrak G.A. Characterization of carbohydrate and lipid metabolism at the onset of different types of diabetes mellitus. Meditsinskiy sovet = Medical Council. 2015;(17):114–116. (In Russ.) Available at: https://elibrary.ru/item.asp?id=25450368.
12. Kuznetsova L.A., Shpakov A.O. Adipokines and their possible role in obesity and type 2 diabetes mellitus (review). Saratovskij nauchno-medicinskij zhurnal = Saratov Journal of Medical Scientific Research. 2018;14(2):201–206. (In Russ.) Available at: http://ssmj.ru/system/files/2018_2_201-206.pdf.
13. Belyaeva O., Bazhenova E.A., Berezina A.V., Bolshakova O.O., Chubenko E.A., Garanina A.E. et al. Adiponectin levels, lipid profile and glucose metabolism in patients with abdominal obesity. Arterial’naya Gipertenziya = Arterial Hypertension. 2009;15(3):309–313. (In Russ.) doi: 10.18705/1607-419X2009-15-3-309-313.
14. Skudaeva E.S., Pashentseva A.V., Verbovoy A.F. Levels of resistin, adiponectin and insulin resistance in patients with varying degrees of carbohydrate metabolism disorders. Ozhirenie i metabolism = Obesity and Metabolism. 2011;8(3):57–60. (In Russ.) doi: 10.14341/2071-8713-4838.
15. Kapralova I.YU., Verbovoy A.F., Sharonova L.A. Concetrration of vitamin D3 and some adipokines in hypothyroidism. Medicina v Kuzbasse = Medicine in Kuzbass. 2014;13(3):42–45. (In Russ.) Available at: http://cyberleninka.ru/article/n/soderzhanie-vitamina-d3-i-nekotoryh-adipokinov-pri-gipotireoze.
16. Saveleva S.A., Kryachkova A.A., Kurumova K.O., Shamkhalova M.S., Kutyrina I.M., Shestakova M.V. Obesity – a risk factor of renal pathology in patients with type 2 diabetes mellitus. Saharnyj diabet = Diabetes Mellitus. 2010;13(2):45–49. (In Russ.) doi: 10.14341/2072-0351-5673.
17. Suslina A.A. Adiponectinemia in type 2 diabetes mellitus in combination with obesity and hypothyroidism. In: Advances in personalised medicine today - the result of practical healthcare tomorrow: collection of abstracts from the VII All-Russian Congress of Endocrinologists. Moscow: UP Print; 2016, pp. 84. (In Russ.) Available at: https://elibrary.ru/item.asp?id=26467517.
18. Guerre-Millo M. Adiponectin: an update. Diabetes Metab. 2008;34(1):12–18. doi: 10.1016/j.diabet.2007.08.002.
19. Burnett M.S., Devaney J.M., Adenika R.J., Lindsay R., Howard B.V. Crosssectional associations of resistin, coronary heart disease, and insulin resistance. J Clin Endocrinol Metab. 2006;91(1):64–68. doi: 10.1210/jc.2005-1653.
20. Hivert M.F., Sullivan L.M., Fox C.S., Nathan D.M., D’Agostino R.B. Sr., Wilson P.W. et al. Associations of adiponectin, resistin and TNF-α with insulin resistance. J Clin Endocrinol Metab. 2008;93(8):3165–3172. doi: 10.1210/jc.2008-0425.
Review
For citations:
Verbovoy AF, Lomonova TV. The content of adipokines in women with hypothyroidism and type 2 diabetes mellitus. Meditsinskiy sovet = Medical Council. 2020;(21):170-177. (In Russ.) https://doi.org/10.21518/2079-701X-2020-21-170-177
Views:
618
Email this article 